Zelgen(SH:688266) Xin Lang Cai Jing·2025-10-16 02:30Group 1 - The core point of the news is that Zai Lab Limited (泽璟制药) experienced a stock price increase of 5.01%, reaching 101.78 CNY per share, with a total market capitalization of 26.942 billion CNY [1] - Zai Lab, established on March 18, 2009, and listed on January 23, 2020, focuses on the research, production, and sales of chemical and biological new drugs, with 99.97% of its revenue coming from pharmaceuticals [1] - The trading volume for Zai Lab was 1.68 million CNY, with a turnover rate of 0.64% [1] Group 2 - Jin Xin Fund has a significant holding in Zai Lab, with its Jin Xin Value Selection Mixed A Fund (005117) owning 17,000 shares, representing 4.59% of the fund's net value, making it the sixth-largest holding [2] - The Jin Xin Value Selection Mixed A Fund has achieved a year-to-date return of 58.74%, ranking 429 out of 8161 in its category, and a one-year return of 71.43%, ranking 323 out of 8021 [2] - The fund was established on September 1, 2017, and has a total size of 15.4432 million CNY [2] Group 3 - The fund managers of Jin Xin Value Selection Mixed A are Liu Shang and Tan Zhiming, with Liu having a tenure of 55 days and a total fund size of 11.3 million CNY, while Tan has a tenure of 190 days and a total fund size of 14.2 million CNY [3] - Liu's best and worst fund returns during his tenure were -2.01% and -13.59%, respectively, while Tan's were 38.66% and -2.48% [3]